Kalif Eliyahu Sharon, EVP and Chief Financial Officer of Teva Pharmaceutical Industries Ltd. ($TEVA), sold shares on the open market twice in the last 365 days for a total of $12.6 million. His most recent sale occurred on February 26, 2026. These sales rank him 945th among 11,678 insiders by total value sold, above the average of $8.6 million across 6.4 transactions per insider. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 19916 | $0.00 | 59,748.0000 | 1,163,000,000 | 25.00% | 0.00% |
| March 5, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 19916 | $0.00 | 325,435.0000 | 1,163,000,000 | 6.52% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 33512 | $0.00 | 0.0000 | 1,163,000,000 | 100.00% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 23251 | $0.00 | 46,503.0000 | 1,163,000,000 | 33.33% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 33512 | $0.00 | 282,268.0000 | 1,163,000,000 | 13.47% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 23251 | $0.00 | 305,519.0000 | 1,163,000,000 | 8.24% | 0.00% |
| March 4, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | A | Restricted Share Units | 53175 | $0.00 | 53,175.0000 | 1,163,000,000 | 9999.99% | 0.00% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 141478 | $0.00 | 0.0000 | 1,163,000,000 | 100.00% | 0.01% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 49800 | $0.00 | 49,802.0000 | 1,163,000,000 | 50.00% | 0.00% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 141478 | $0.00 | 248,756.0000 | 1,163,000,000 | 131.88% | 0.01% |
| March 3, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 49800 | $0.00 | 107,278.0000 | 1,163,000,000 | 86.64% | 0.00% |
| Feb. 26, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | S | Ordinary Shares | 345810 | $33.64 | 57,478.0000 | 1,163,000,000 | 85.75% | 0.03% |
| Jan. 27, 2026 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | A | Restricted Share Units | 141478 | $0.00 | 141,478.0000 | 1,163,000,000 | 9999.99% | 0.01% |
| June 12, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | S | Ordinary Shares | 55775 | $17.08 | 403,288.0000 | 1,159,000,000 | 12.15% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 21390 | $0.00 | 459,063.0000 | 1,131,000,000 | 4.89% | 0.00% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | A | Restricted Share Units | 79664 | $0.00 | 79,664.0000 | 1,131,000,000 | 9999.99% | 0.01% |
| March 5, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 21390 | $0.00 | 0.0000 | 1,131,000,000 | 100.00% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 23251 | $0.00 | 254,504.0000 | 1,131,000,000 | 10.05% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 33512 | $0.00 | 231,253.0000 | 1,131,000,000 | 16.95% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 183169 | $0.00 | 437,673.0000 | 1,131,000,000 | 71.97% | 0.02% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 33512 | $0.00 | 33,512.0000 | 1,131,000,000 | 50.00% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 23251 | $0.00 | 69,754.0000 | 1,131,000,000 | 25.00% | 0.00% |
| March 4, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 183169 | $0.00 | 0.0000 | 1,131,000,000 | 100.00% | 0.02% |
| Feb. 28, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | S | Ordinary Shares | 55750 | $16.21 | 147,941.0000 | 1,131,000,000 | 27.37% | 0.00% |
| March 3, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 49800 | $0.00 | 99,602.0000 | 1,131,000,000 | 33.33% | 0.00% |
| March 3, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 49800 | $0.00 | 197,741.0000 | 1,131,000,000 | 33.66% | 0.00% |
| Jan. 28, 2025 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | A | Restricted Share Units | 183169 | $0.00 | 183,169.0000 | 1,131,000,000 | 9999.99% | 0.02% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 21387 | $0.00 | 281,241.0000 | 1,119,000,000 | 8.23% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 52320 | $0.00 | 259,854.0000 | 1,119,000,000 | 25.21% | 0.00% |
| March 6, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | S | Ordinary Shares | 77550 | $13.52 | 203,691.0000 | 1,119,000,000 | 27.57% | 0.01% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 21387 | $0.00 | 21,390.0000 | 1,119,000,000 | 50.00% | 0.00% |
| March 5, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 52320 | $0.00 | 0.0000 | 1,119,000,000 | 100.00% | 0.00% |
| March 3, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 49800 | $0.00 | 174,022.0000 | 1,119,000,000 | 40.09% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 33512 | $0.00 | 207,534.0000 | 1,119,000,000 | 13.90% | 0.00% |
| March 3, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 49800 | $0.00 | 174,022.0000 | 1,119,000,000 | 22.25% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 33512 | $0.00 | 207,534.0000 | 1,119,000,000 | 19.26% | 0.00% |
| March 4, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | A | Restricted Share Units | 93005 | $0.00 | 93,005.0000 | 1,119,000,000 | 9999.99% | 0.01% |
| Feb. 28, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 18430 | $0.00 | 0.0000 | 1,119,000,000 | 100.00% | 0.00% |
| Feb. 28, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 18430 | $0.00 | 124,222.0000 | 1,119,000,000 | 17.42% | 0.00% |
| Feb. 13, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Restricted Share Units | 6630 | $0.00 | 0.0000 | 1,119,000,000 | 100.00% | 0.00% |
| Feb. 13, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | M | Ordinary Shares | 6630 | $0.00 | 105,792.0000 | 1,119,000,000 | 6.69% | 0.00% |
| Jan. 30, 2024 | TEVA PHARMACEUTICAL INDUSTRIES LTD | $TEVA | Kalif Eliyahu Sharon | EVP, Chief Financial Officer | A | Restricted Share Units | 52320 | $0.00 | 52,320.0000 | 1,119,000,000 | 9999.99% | 0.00% |